1-3 of 3
Evangelos Eleftherakis-Papaiakovou, MD
Close
Sort by
Journal Articles

The International Prognostic Scoring System for Waldestrom’s Macroglobulinemia (ISSWM) Is Applicable in Patients Treated with Rituximab-Based Regimens.

Meletios Athanasios Dimopoulos, MD, Efstathios Kastritis, MD, Dimitra Gika, Sossana Delimpassi, MD, Konstantinos Zervas, MD, Argiris Simeonidis, MD, Evangelos Eleftherakis-Papaiakovou, MD, Nicolaos Anagnostopoulos, MD, Evridiki Michali, MD, Marie Christine Kyrtsonis, MD, Evangelos Terpos, MD, Gerassimos Pangalis, MD
Journal: Blood
Blood (2007) 110 (11): 3615.
https://doi.org/10.1182/blood.V110.11.3615.3615
Published: 2007
Journal Articles

Symptomatic Waldenstrom’s Macroglobulinemia (WM) in Young Patients: Disease Characteristics and Outcome.

Efstathios Kastritis, MD, Evangelos Eleftherakis-Papaiakovou, MD, Magdalini Migkou, MD, Dimitra Gika, Evangelos Terpos, MD, Konstantinos Zervas, MD, Marie Christine Kyrtsonis, MD, Nicolaos Anagnostopoulos, MD, Sossana Delimpassi, MD, Argiris Symeonidis, MD, Meletios Athanasios Dimopoulos, MD
Journal: Blood
Blood (2007) 110 (11): 4730.
https://doi.org/10.1182/blood.V110.11.4730.4730
Published: 2007
Journal Articles

Thalidomide Based Regimens (TBR) for Relapsed/Refractory Multiple Myeloma Patients: Long Term Follow Up, Unmaintained Remissions and Disease Control after Subsequent Treatments.

Maria Roussou, MD, Efstathios Kastritis, MD, Athanasios Anagnostopoulos, MD, Evangelos Eleftherakis-Papaiakovou, MD, Charis Matsouka, MD, Despina Barmparousi, MD, Magdalini Migkou, MD, Meletios Athanasios Dimopoulos, MD
Journal: Blood
Blood (2007) 110 (11): 4812.
https://doi.org/10.1182/blood.V110.11.4812.4812
Published: 2007